ISSN: 1084-9785

Journal Home

Journal Guideline

Cancer Biotherapy and Radiopharmaceuticals Q2 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Biotherapy and Radiopharmaceuticals is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 68. It has an SJR impact factor of 0,607 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,607.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Pharmacology (Q2) Radiology, Nuclear Medicine and Imaging (Q2) Cancer Research (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cancer Biotherapy and Radiopharmaceuticals

0,607

SJR Impact factor

68

H Index

91

Total Docs (Last Year)

285

Total Docs (3 years)

3180

Total Refs

871

Total Cites (3 years)

281

Citable Docs (3 years)

2.79

Cites/Doc (2 years)

34.95

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals